Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>To discover candidate drugs to repurpose for COVID-19 using literature-derived knowledge and knowledge graph completion methods.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>We propose a novel, integrative, and neural network-based literature-based discovery (LBD) approach to identify drug candidates from PubMed and other COVID-19-focused research literature. Our approach relies on semantic triples extracted using SemRep (via SemMedDB). We identified an informative and accurate subset of semantic triples using filtering rules and an accuracy classifier developed on a BERT variant. We used this subset to construct a knowledge graph, and applied five state-of-the-art, neural knowledge graph completion algorithms (TransE, RotatE, DistMult, ComplEx, and STELP) to predict drug repurposing candidates. The models were trained and assessed using a time slicing approach and the predicted drugs were compared with a list of drugs reported in the literature and evaluated in clinical trials. These models were complemented by a discovery pattern-based approach.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Accuracy classifier based on PubMedBERT achieved the best performance (F<sub>1</sub> = 0.854) in classifying semantic predications. Among five knowledge graph completion models, TransE outperformed others (MR = 0.923, = 0.417). Some known drugs linked to COVID-19 in the literature were identified, as well as others that have not yet been studied. Discovery patterns enabled identification of additional candidate drugs and generation of plausible hypotheses regarding the links between the candidate drugs and COVID-19. Among them, five highly ranked and novel drugs (paclitaxel, SB 203580, alpha 2-antiplasmin, metoclopramide, and oxymatrine) and the mechanistic explanations for their potential use are further discussed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>We showed that a LBD approach can be feasible not only for discovering drug candidates for COVID-19, but also for generating mechanistic explanations. Our approach can be generalized to other diseases as well as to other clinical questions. Source code and data are available at https://github.com/kilicogluh/lbd-covid.</p>

DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing

Knowledge-driven drug repurposing using a comprehensive drug knowledge graph

SynDRep: A Knowledge Graph-Enhanced Tool based on Synergistic Partner Prediction for Drug Repurposing

Analysis of Drug repurposing Knowledge graphs for Covid-19

Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

Drug repurposing for COVID-19 via knowledge graph completion

Dr-COVID: Graph Neural Networks for SARS-CoV-2 Drug Repurposing

A knowledge graph approach to drug repurposing for Alzheimer's, Parkinson's and Glioma using drug-disease-gene associations

Generating Drug Repurposing Hypotheses through the Combination of Disease-Specific Hypergraphs

Drug Repositioning with GraphSAGE and Clustering Constraints Based on Drug and Disease Networks

EKGDR: An End-to-End Knowledge Graph-Based Method for Computational Drug Repurposing

Drug Repurposing using Consilience of Knowledge Graph Completion Methods

Uncovering hidden therapeutic indications through drug repurposing with graph neural networks and heterogeneous data

Drug repositioning based on the heterogeneous information fusion graph convolutional network

A novel efficient drug repurposing framework through drug-disease association data integration using convolutional neural networks

SiSGC: A Drug Repositioning Prediction Model Based on Heterogeneous Simplifying Graph Convolution.

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Using TransR to Enhance Drug Repurposing Knowledge Graph for COVID-19 and Its Complications

Drug repurposing against breast cancer by integrating drug-exposure expression profiles and drug–drug links based on graph neural network

A Multimodal Framework for Improving in Silico Drug Repositioning with the Prior Knowledge from Knowledge Graphs